Home LiteratureArticle Details
PMID: 12082592 Published · ppublish English Clinical Trial Journal Article Research Support, U.S. Gov't, P.H.S.

Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex disease.

The pharmacogenomics journal ·Vol. 2 ·No. 3 ·2002-00-00 ·Pages 197-201

Zee RY, Hoh J, Cheng S, Reynolds R, Grow MA, Silbergleit A, Walker K, Steiner L, Zangenberg G, Fernandez-Ortiz A, Macaya C, Pintor E, Fernandez-Cruz A, Ott J, Lindpainter K

Abstract

The complexity of recognizing the potential contribution of a number of possible predictors of complex disorders is increasingly challenging with the application of large-scale single nucleotide polymorphism (SNP) typing. In the search for putative genetic factors predisposing to coronary artery restenosis following balloon angioplasty, we determined genotypes for 94 SNPs representing 62 candidate genes, in a prospectively assembled cohort of 342 cases and 437 controls. Using a customized coupled-logistic regression procedure accounting for both additive and interactive effects, we identified seven SNPs in seven genes that, together, showed a statistically significant association with restenosis incidence (P <0.0001), accounting for 11.6% of overall variance observed. Among them are candidate genes for cardiovascular pathophysiology (apolipoprotein-species and NOS), inflammatory response (TNF receptor and CD14), and cell-cycle control (p53 and p53-associated protein). Our results emphasize the need to account for complex multi-gene influences and interactions when assessing the molecular pathology of multifactorial medical entities.

MeSH Terms
Angioplasty, Balloon, Coronary Cardiovascular Diseases/epidemiology Cell Cycle/genetics Cohort Studies Constriction, Pathologic/epidemiology,genetics Genetic Markers Humans Inflammation/genetics Logistic Models Polymorphism, Genetic/genetics Predictive Value of Tests Prospective Studies Recurrence Risk Assessment
Chemicals
Genetic Markers
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Zee R Y L
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Hoh J
Cheng S
Reynolds R
Grow M A
Silbergleit A
Walker K
Steiner L
Zangenberg G
Fernandez-Ortiz A
Macaya C
Pintor E
Fernandez-Cruz A
Ott J
Lindpainter K
Article Info
Journal
The pharmacogenomics journal
Abbr.
Pharmacogenomics J
ISSN
1470-269X
Published
2002-00-00
Pages
197-201
Language
English
Region
United States
NLM ID
101083949
Subset
IM
Grants
NHGRI NIH HHS · HG00008 · United States
NHLBI NIH HHS · K04-HL-03138-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com